Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Carolyn Vachani, RN, MSN, AOCN
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de junio del 2008
Non-small cell lung cancer (NSCLC) remains the number one cause of cancer death in both men and women in the United States. The greatly increased risk of NSCLC development in tobacco users has been well recognized for several decades. More recently, a sharp rise has been seen in NSCLC among never smokers and this cancer has been found to be biologically different from that of a NSCLC in a current of former smoker. Common features of never-smokers with NSCLC have been identified, including East Asian ethnicity, female sex, adenocarcinoma (specifically bronchoalveolar) pathology, and an increased likelihood of EGFR mutations, which may result in different therapy choices. This study attempted to increase the understanding of the epidemiology (the occurrence and distribution) of NSCLC in never smokers and to look at the affect of ethnicity on prognosis.
Utilizing a southern California database that included smoking status, 2240 never smokers were identified with a NSCLC diagnosis (and compared with 22964 current and former smokers). Never smokers had significantly improved survival when compared with smokers. Never smokers responded better to chemotherapy, with an 8 month median survival in never-smokers versus 6 month median survival in smokers with metastatic disease receiving chemotherapy. Response to radiation therapy also appears to be better.
When the never smokers (NS) were compared to the smokers (SK), the NS group contained more females, their tumors were more likely to be adenocarcinoma and more specifically, bronchoaveolar. When looking at ethnicity, 13% of Caucasian women were NS, 45% of Asian women were NS, and 25% of Hispanic women were NS. Of women born in North America, 11% of women born in Canada and 12% of women born in the United States with NSCLC were never-smokers. Thirty percent of women born in Mexico with NSCLC were never smokers. Of women born in Asian countries with NSCLC, 53% of Philippine women, 64% of Vietnamese women, 17% of Japanese women, and 61% of Chinese women were never-smokers.
Being of Asian ethnicity was a favorable prognostic sign for both NSs and SKs. Other groups have demonstrated improved responses among Asian women to certain therapies. While the information from this study is interesting, actual treatments were not considered and the population was limited to one geographic area. It is unclear what is driving the rise in these ethnic groups. Further studies must look at exposures and genetics as possible causes and evaluate how ethnic factors play into treatment decisions.
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults